Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC

Integrating Emerging Science and Earlier Detection Practices to Play Our Part in Controlling Cancer

Access Activity

Overview / Abstract:

Target Audience
This educational program is directed toward internists and internal medicine subspecialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in screening patients for cancer will be also invited to participate.

Program Overview
This online, on-demand virtual symposium brings together renowned experts in early cancer detection. Primary care providers (PCPs), not oncologists, are usually the first point of contact for a patient at risk for cancer or needing an evaluation for cancer. Typically, in the United States, cancer screenings begin in primary care offices. The development of blood-based cancer tests—analysis of blood obtained in a noninvasive or minimally invasive manner for biomarkers of malignancy—offers the potential for a new era of earlier cancer detection. As trials generate data on the effectiveness of these tests, PCPs require education on how they work, how to encourage patients to utilize them, how to communicate results to patients, and how to fit testing into multidisciplinary patient care pathways within their workflow. PCPs play a key role on the front line of early cancer detection. However, they face many barriers that reduce their effectiveness in identifying cancer in its early stages. In addition, enduring inequality in patient access to screening results in worse prognoses and outcomes for vulnerable patient populations.This panel discussion brings together experts in the development of these screening tests to discuss their implications for PCPs and their patients.

This educational activity is an archive of a live virtual symposium held on April 30, 2021.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Outline current evidence-based guidelines in cancer screening for early detection
Review current evidence on biomarkers targeted by blood-based tests for cancer detection
Evaluate the sensitivity and specificity of blood-based tests for cancer detection
Utilize patient-centered approaches to integrate blood-based testing in screening and diagnosis of patients with cancer

Expiration

May 18, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.5

Accreditation

ACCME

Presenters / Authors / Faculty

Paul P. Doghramji, MD, FAAFP
Tomasz M. Beer, MD
Shannon L. Stott, PhD

Sponsors / Supporters / Grant Providers

Grail Inc

Keywords / Search Terms

Relias LLC Relias, Free CME, Cancer Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map